Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 7862469, 10 pages
http://dx.doi.org/10.1155/2016/7862469
Review Article

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis

1Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang 110001, China
2Department of Dermatology, First Hospital of China Medical University, Shenyang 110001, China

Received 9 September 2015; Accepted 31 December 2015

Academic Editor: Wilbur B. Bowne

Copyright © 2016 Jingxu Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA—Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Wang, Y.-F. Li, X.-W. Sun et al., “Prognosis of 980 patients with gastric cancer after surgical resection,” Chinese Journal of Cancer, vol. 29, no. 11, pp. 923–930, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Fujiwara, S. Takiguchi, K. Nakajima et al., “Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination,” Annals of Surgical Oncology, vol. 18, no. 13, pp. 3726–3731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Kunisaki, M. Takahashi, H. Makino et al., “Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer,” Cancer Chemotherapy and Pharmacology, vol. 67, no. 6, pp. 1363–1368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. M. Yoon, K. W. Ryu, B. H. Nam et al., “Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?” Journal of the American College of Surgeons, vol. 214, no. 1, pp. 88–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. B. Aggarwal, R. V. Vijayalekshmi, and B. Sung, “Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe,” Clinical Cancer Research, vol. 15, no. 2, pp. 425–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Nozoe, T. Iguchi, E. Adachi, A. Matsukuma, and T. Ezaki, “Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer,” Surgery Today, vol. 41, no. 4, pp. 510–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Mönig, D. Marquardt, T. Arendt, and S. Kloehn, “Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy,” Family Practice, vol. 19, no. 5, pp. 436–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pichler, G. C. Hutterer, C. Stoeckigt et al., “Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients,” British Journal of Cancer, vol. 108, no. 4, pp. 901–907, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. S. Oh, J. W. Jang, J. H. Kwon et al., “Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma,” BMC Cancer, vol. 13, article 78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Chua, K. A. Charles, V. E. Baracos, and S. J. Clarke, “Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer,” British Journal of Cancer, vol. 104, no. 8, pp. 1288–1295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Jiang, J.-Y. Deng, Y. Liu, B. Ke, H.-G. Liu, and H. Liang, “The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer,” Biomarkers, vol. 19, no. 6, pp. 444–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D.-S. Wang, C. Ren, M.-Z. Qiu et al., “Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer,” Tumor Biology, vol. 33, no. 3, pp. 749–756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” PLoS Medicine, vol. 6, no. 7, Article ID e1000100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. A. Wells, B. Shea, D. O'Connell et al., “The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses,” http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  17. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, article 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Mohri, K. Tanaka, M. Ohi et al., “Identification of prognostic factors and surgical indications for metastatic gastric cancer,” BMC Cancer, vol. 14, no. 1, article 409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Graziosi, E. Marino, V. De Angelis, A. Rebonato, E. Cavazzoni, and A. Donini, “Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer,” The American Journal of Surgery, vol. 209, no. 2, pp. 333–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. I. R. Cho, J. C. Park, C. H. Park et al., “Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer,” Gastric Cancer, vol. 17, no. 4, pp. 703–710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Aurello, S. M. Tierno, G. Berardi et al., “Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer,” Annals of Surgical Oncology, vol. 21, no. 6, pp. 1998–2004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. M. A. El Aziz, “Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4,” Medical Oncology, vol. 31, article 311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Lee, S. Y. Oh, S. H. Kim et al., “Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy,” BMC Cancer, vol. 13, article 350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Y. Lee, S. W. Hong, Y. G. Chang, W. Y. Lee, and B. Lee, “Clinical significance of preoperative inflammatory parameters in gastric cancer patients,” Journal of Gastric Cancer, vol. 13, no. 2, pp. 111–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Jin, G. Zhang, X. Liu et al., “Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy,” World Journal of Surgical Oncology, vol. 11, article 112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Dirican, N. Ekinci, A. Avci et al., “The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer,” Cancer Biomarkers, vol. 13, no. 1, pp. 11–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Kunisaki, M. Takahashi, H. A. Ono et al., “Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and S-1 combination chemotherapy,” Oncology, vol. 83, no. 4, pp. 183–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. H. Kim and W. J. Choi, “The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery,” Journal of the Korean Surgical Society, vol. 83, no. 6, pp. 352–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Jeong, S. M. Lim, J. Y. Yun et al., “Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer,” Oncology, vol. 83, no. 5, pp. 292–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Jung, Y. K. Park, O. Jeong et al., “Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer,” Journal of Surgical Oncology, vol. 104, no. 5, pp. 504–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Ubukata, G. Motohashi, T. Tabuchi, H. Nagata, S. Konishi, and T. Tabuchi, “Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients,” Journal of Surgical Oncology, vol. 102, no. 7, pp. 742–747, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Shimada, N. Takiguchi, O. Kainuma et al., “High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer,” Gastric Cancer, vol. 13, no. 3, pp. 170–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Mohri, K. Tanaka, M. Ohi, T. Yokoe, C. Miki, and M. Kusunoki, “Prognostic significance of host- and tumor-related factors in patients with gastric cancer,” World Journal of Surgery, vol. 34, no. 2, pp. 285–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Yamanaka, S. Matsumoto, S. Teramukai, R. Ishiwata, Y. Nagai, and M. Fukushima, “The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer,” Oncology, vol. 73, no. 3-4, pp. 215–220, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Y. Shau and S. H. Golub, “Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils,” Journal of Immunology, vol. 143, no. 3, pp. 1066–1072, 1989. View at Google Scholar · View at Scopus
  36. M. R. Hussein and R. A. Ahmed, “Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin,” Cancer Biology & Therapy, vol. 4, no. 8, pp. 819–821, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. B. Cihan, A. Ozturk, and H. Mutlu, “Relationship between prognosis and neutrophil: lymphocyte and platelet: Lymphocyte ratios in patients with malignant pleural mesotheliomas,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 2061–2067, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Wei, Y.-Z. Jiang, and W.-H. Qian, “Prognostic role of NLR in urinary cancers: a meta-analysis,” PLoS ONE, vol. 9, no. 3, Article ID e92079, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-X. Li, X.-M. Liu, X.-F. Zhang et al., “Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis,” International Journal of Cancer, vol. 134, no. 10, pp. 2403–2413, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Malietzis, M. Giacometti, R. H. Kennedy, T. Athanasiou, O. Aziz, and J. T. Jenkins, “The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis,” Annals of Surgical Oncology, vol. 21, no. 12, pp. 3938–3946, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Matsumoto, H. Marusawa, K. Kinoshita et al., “Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium,” Nature Medicine, vol. 13, no. 4, pp. 470–476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. H. Kusumanto, W. A. Dam, G. A. P. Hospers, C. Meijer, and N. H. Mulder, “Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor,” Angiogenesis, vol. 6, no. 4, pp. 283–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Jablonska, W. Puzewska, Z. Grabowska, J. Jablonski, and L. Talarek, “VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer,” Cytokine, vol. 30, no. 3, pp. 93–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. V. C. Ardi, T. A. Kupriyanova, E. I. Deryugina, and J. P. Quigley, “Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 51, pp. 20262–20267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Smyth, G. P. Dunn, and R. D. Schreiber, “Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity,” Advances in Immunology, vol. 90, pp. 1–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Martinet, I. Garrido, T. Filleron et al., “Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer,” Cancer Research, vol. 71, no. 17, pp. 5678–5687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. H. T. Petrie, L. W. Klassen, and H. D. Kay, “Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes,” The Journal of Immunology, vol. 134, no. 1, pp. 230–234, 1985. View at Google Scholar · View at Scopus
  48. P. R. Rohatgi, J. C. Yao, K. Hess et al., “Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival,” Cancer, vol. 107, no. 11, pp. 2576–2580, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. B. V. Hogan, M. B. Peter, H. G. Shenoy, K. Horgan, and T. A. Hughes, “Surgery induced immunosuppression,” Surgeon, vol. 9, no. 1, pp. 38–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Zhang, W. Zhang, and L.-J. Feng, “Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis,” PLoS ONE, vol. 9, no. 11, Article ID e111906, 2014. View at Publisher · View at Google Scholar · View at Scopus